BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 7522951)

  • 21. Colour flow Doppler for gestational trophoblastic neoplasia.
    Flam F
    Eur J Gynaecol Oncol; 1994; 15(6):443-8. PubMed ID: 7533078
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Human chorionic gonadotropin (hCG) beta-core fragment is produced by degradation of hCG or free hCG beta in gestational trophoblastic tumors: a possible marker for early detection of persistent postmolar gestational trophoblastic disease.
    Okamoto T; Matsuo K; Niu R; Osawa M; Suzuki H
    J Endocrinol; 2001 Dec; 171(3):435-43. PubMed ID: 11739009
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Assessment of uterine artery and arcuate artery blood flow by transvaginal color Doppler ultrasound on the day of human chorionic gonadotropin administration as predictors of pregnancy in an in vitro fertilization program.
    Ivanovski M; Damcevski N; Radevska B; Doicev G
    Akush Ginekol (Sofiia); 2012; 51(2):55-60. PubMed ID: 23234017
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Trophoblastic pregnancy persistant disease with a menopausal woman: ultrasonography-Doppler benefits].
    Benabu-Saada L; Roussel E; Body G; Marret H
    Gynecol Obstet Fertil; 2008 Apr; 36(4):403-6. PubMed ID: 18420442
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Radioimmunoassay of free beta-subunit of human chorionic gonadotropin in diagnosis of high-risk and low-risk gestational trophoblastic disease.
    Khazaeli MB; Buchina ES; Pattillo RA; Soong SJ; Hatch KD
    Am J Obstet Gynecol; 1989 Feb; 160(2):444-9. PubMed ID: 2464935
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Value of the radioimmunological assay of HCG and its subunits in the diagnosis and follow-up of gestational trophoblastic disease].
    Delpont PJ; Ruf H; Blanc B; Gamerre M; Adrai J; Conte M; Dupont S; Bellia-Rousseau J
    Rev Fr Gynecol Obstet; 1985 Oct; 80(10):737-52. PubMed ID: 2417299
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Development of single-agent chemotherapy regimens for gestational trophoblastic disease.
    Homesley HD
    J Reprod Med; 1994 Mar; 39(3):185-92. PubMed ID: 7518517
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of the criteria used to make the diagnosis of nonmetastatic gestational trophoblastic neoplasia.
    Kohorn EI
    Gynecol Oncol; 1993 Feb; 48(2):139-47. PubMed ID: 8381374
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Trophoblastic cell sensitivity to 8-day chemotherapy in nonmetastatic gestational trophoblastic neoplasia.
    Hilgers RD; Standefer JC; Rutledge JM; Ampuero F
    Gynecol Oncol; 1984 Mar; 17(3):386-93. PubMed ID: 6200387
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Schwangerschaftsprotein 1 (SP1) in serum and cerebrospinal fluid of patients with gestational trophoblastic disease.
    Ho PC; Ma HK
    Br J Obstet Gynaecol; 1983 Apr; 90(4):317-22. PubMed ID: 6188478
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Magnetic resonance imaging in patients with gestational trophoblastic disease.
    Preidler KW; Luschin G; Tamussino K; Szolar DM; Stiskal M; Ebner F
    Invest Radiol; 1996 Aug; 31(8):492-6. PubMed ID: 8854195
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Regression pattern of beta human chorionic gonadotrophin in blood after chemotherapy for gestational trophoblastic neoplasia.
    Burrows A; Faddy MJ; Khoo SK
    Aust N Z J Obstet Gynaecol; 1996 Aug; 36(3):331-4. PubMed ID: 8883763
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Transvaginal ultrasonography in persistent trophoblastic tumor.
    Mangili G; Spagnolo D; Valsecchi L; Maggi R
    Am J Obstet Gynecol; 1993 Nov; 169(5):1218-23. PubMed ID: 8238187
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Treatment of gestational trophoblastic disease.
    Seckl MJ; Newlands ES
    Gen Diagn Pathol; 1997 Nov; 143(2-3):159-71. PubMed ID: 9443572
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Study on the indication of surgical resection of pulmonary metastasis of malignant trophoblastic tumor].
    Zhang Y; Xiang Y; Ren T; Wan XR; Yang XY
    Zhonghua Fu Chan Ke Za Zhi; 2005 Feb; 40(2):83-6. PubMed ID: 15840284
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Histological origins of discordant chorionic gonadotropin secretion in malignancy.
    Hay DL
    J Clin Endocrinol Metab; 1988 Mar; 66(3):557-64. PubMed ID: 2450890
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Medroxyprogesterone acetate in non-metastatic gestational trophoblastic disease.
    Goldberg GL; Cloete K; Bloch B; Wiswedel K; Altaras MM
    Br J Obstet Gynaecol; 1987 Jan; 94(1):22-5. PubMed ID: 2434125
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Elevated sera levels of SP-1 induced by chemotherapy in patients with metastatic gestational trophoblastic diseases.
    Göcze PM; Than GN; Szabò DG; Csaba IF; Bohn H
    Oncology; 1990; 47(5):406-9. PubMed ID: 1699189
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Digital subtraction angiography for the evaluation of persistent uterine trophoblastic disease.
    Oka M; Fukuda O; Katabuchi H; Maeyama M; Takahashi M
    Obstet Gynecol; 1984 Mar; 63(3 Suppl):66S-71S. PubMed ID: 6322076
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sonographic appearance of gestational trophoblastic disease evolving into epithelioid trophoblastic tumor.
    Okumura M; Fushida K; Rezende WW; Schultz R; Zugaib M
    Ultrasound Obstet Gynecol; 2010 Aug; 36(2):249-51. PubMed ID: 20069561
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.